Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.

about

Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.

Item

http://www.wikidata.org/entity/Q47146451

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@en

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@nl

type

Item

label

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@en

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@nl

prefLabel

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@en

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@nl

P1476

Therapeutic Drug Monitoring of ...... nas aeruginosa: A Case Report.

@en

P2093

Arun Chopra

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Cies

http://www.w3.org/2001/XMLSchema#string

Richard J LaCoursiere

http://www.w3.org/2001/XMLSchema#string

Wayne S Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa.

Single-dose pharmacokinetics of aztreonam in pediatric patients

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.

Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Augmented renal clearance: implications for antibacterial dosing in the critically ill.

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.

P304

467-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.5863/1551-6776-22.6.467

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29290748

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5736260

http://www.w3.org/2001/XMLSchema#string